Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis

Contemporary Clinical Trials

Volumn 33, Issue 4, 2012, Pages 848-852

  Ciccolo, Joseph T ^a   Lo, Albert C ^b   Jennings, Ernestine G ^c   Motl, Robert W ^d  

^a MIRIAM HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Multiple sclerosis; Resistance training; Smoking cessation

Indexed keywords

CARBON MONOXIDE; NICOTINE;

ABSTINENCE; ADULT; AGED; ARTICLE; BREATH ANALYSIS; CONTROLLED STUDY; COUNSELING; DRUG DOSE REDUCTION; FATIGUE; FEMALE; FOLLOW UP; HEALTH EDUCATION; HUMAN; MALE; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RESISTANCE TRAINING; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGED; CLINICAL PROTOCOLS; DIRECTIVE COUNSELING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REGRESSION ANALYSIS; RESEARCH DESIGN; RESISTANCE TRAINING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861531458     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2012.04.010     Document Type: Article

References (43)

1. Mayr W.T., Pittock S.J., McClelland R.L., Jorgensen N.W., Noseworthy J.H., Rodriguez M. Incidence and prevalence of multiple sclerosis in Olmstead County, Minnesota, 1985-2000. Neurology 2003, 61:1373-1377.
2. Wallin M.T., Page W.F., Kurtzke J.F. Epidemiology of multiple sclerosis in US veterans VIII. Long term survival after onset of multiple sclerosis. Brain 2000, 123:1677-1687.
3. Hemmer B., Nessler S., Zhou D., Kieseier B., Hartung H.P. Immunopathogenesis and immunotherapy of multiple sclerosis. Nat Clin Pract Neurol 2006, 2:201-211.
4. National Multiple Sclerosis Society Multiple sclerosis information sourcebook 2003, Information Resource Center and Library of the National Multiple Sclerosis Society, New York, NY.
5. National Center for Health Statistics Health, United States, 2010: with special feature on death and dying 2011, [Hyattsville, MD].
6. Wingerchuk D.M. Smoking: effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord. 2012, 5:13-22.
7. Hernán M.A., Olek M.J., Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001, 154:69-74.
8. Di Pauli F., Reindl M., Ehling R., Schautzer F., Gneiss C., Lutterotti A., et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 2008, 14:1026-1030.
9. Hernán M.A., Jick S.S., Logroscino G., Olek M.J., Ascherio A., Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 2005, 128(Pt 6):1461-1465.
10. Zivadinov R., Weinstock-Guttman B., Hashmi K., Abdelrahman N., Stosic M., Dwyer M., et al. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 2009, 73:504-510.
11. Healy B.C., Ali E.N., Guttmann C.R., Chitnis T., Glanz B.I., Buckle G., et al. Smoking and disease progression in multiple sclerosis. Arch Neurol 2009, 66:858-864.
12. Friend K.B., Mernoff S.T., Block P., Reeve G. Smoking rates and smoking cessation among individuals with multiple sclerosis. Disabil Rehabil 2006, 28:1135-1141.
13. Turner A.P., Kivlahan D.R., Kazis L.E., Haselkorn J.K. Smoking among veterans with multiple sclerosis: prevalence correlates, quit attempts, and unmet need for services. Arch Phys Med Rehabil 2007, 88:1394-1399.
14. Marrie R.A., Cutter G., Tyry T., Campagnolo D., Vollmer T. Smoking status over two years in patients with multiple sclerosis. Neuroepidemiology 2009, 32:72-79.
15. Ussher M.H., Taylor A.H., Faulkner G. Exercise interventions for smoking cessation. Cochrane Database Syst Rev 2012, CD002295.
16. Taylor A.H., Ussher M.H., Faulkner G. The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behaviour: a systematic review. Addiction 2007, 102:534-543.
17. Arent S.M., Landers D.M., Matt K.S., Etnier J.L. Dose-response and mechanistic issues in the resistance training and affect relationship. J Sport Exerc Psychol 2005, 27:92-110.
18. Donnelly J.E., Blair S.N., Jakicic J.M., Manore M.M., Rankin J.W., Smith B.K., et al. American College of Sports Medicine position stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009, 41:459-471.
19. Ciccolo J.T., Dunsiger S.I., Williams D.M., Bartholomew J.B., Jennings E.G., Ussher M.H., et al. Resistance training as an aid to standard smoking cessation treatment: a pilot study. Nicotine Tob Res 2011, 13:756-760.
20. Cameron M.H., Lord S. Postural control in multiple sclerosis: implications for fall prevention. Curr Neurol Neurosci Rep 2010, 10:407-412. [Review].
21. Martin C.L., Phillips B.A., Kilpatrick T.J., Butzkueven H., Tubridy N., McDonald E., et al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 2006, 12:620-628.
22. de Souza-Teixeira F., Costilla S., Ayán C., García-López D., González-Gallego J., de Paz J.A. Effects of resistance training in multiple sclerosis. Int J Sports Med 2009, 30:245-250.
23. Dalgas U., Stenager E., Jakobsen J., Petersen T., Hansen H.J., Knudsen C., et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 2009, 73:1478-1484.
24. Dalgas U., Stenager E., Jakobsen J., Petersen T., Hansen H.J., Knudsen C., et al. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Mult Scler 2010, 16:480-490.
25. Hurwitz B.J. The diagnosis of multiple sclerosis and the clinical subtypes. Ann Indian Acad Neurol 2009, 12:226-230.
26. Cipriani A., Geddes J.R. What is a run-in phase?. Epidemiol Psychiatr Soc 2010, 19:21-22.
27. Centers for Disease Control "You Can Quit Smoking" consumer guide [Accessed August 29, 2011]. http://www.cdc.gov/tobacco/quit_smoking/you_can_quit/five_keys.htm.
28. Fiore M.C., Jaen R.C., Baker T.B., Bailey W.C., Benowitz N.L., Curry S.J., et al. Treating tobacco use and dependence: 2008 update 2008, US Department of Health & Human Services, Public Health Service, Rockville, MD.
29. Borrelli B., Sepinwall D., Ernst D., Belig A.J., Czajkowski S., Breger R., et al. A new tool to assess treatment fidelity and evaluation of treatment fidelity across ten years of health behavior research. J Consult Clin Psychol 2005, 73:852-860.
30. McAuley E., Motl R.W., Morris K.S., Hu L., Doerksen S.E., Elavsky S., et al. Enhancing physical activity adherence and well-being in multiple sclerosis: a randomised controlled trial. Mult Scler 2007, 13:652-659.
31. American College of Sports Medicine (ACSM) American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 2009, 41:687-688.
32. Heatherton T., Lozlowski L., Frecker T., Fagerstrom K. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86:1119-1127.
33. Etter J.F., Bergman M.M., Humair J., Perneger T.V. Development and validation of a scale measuring self-efficacy of current and former smokers. Addiction 2000, 95:901-913.
34. West R., Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology 2004, 177:195-199.
35. Krupp L.B., LaRocca N.G., Muir-Nash J., Steinberg A.D. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46:1121-1123.
36. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975, 1:277-299.
37. Hobart J.C., Riazi A., Lamping D.L., Fitzpatrick R., Thompson A.J. Measuring the impact of MS on walking ability: the 12-item multiple sclerosis walking scale (MSWS-12). Neurology 2003, 60:31-36.
38. Hobart J., Lamping D., Fitzpatrick R., Riazi A., Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001, 124(Pt 5):962-973.
39. Tarrasch R., Laudon M., Zisapel N. Cross-cultural validation of the Leeds Sleep Evaluation Questionnaire (LSEQ) in insomnia patients. Hum Psychopharmacol 2003, 18:603-610.
40. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983, 33:1444-1452.
41. Bosma L.V., Kragt J.J., Knol D.L., Polman C.H., Uitdehaag B.M. Clinical scales in progressive MS: predicting long-term disability. Mult Scler 2012, 18:345-350.
42. Oxford Grice K., Vogel K.A., Le V., Mitchell A., Muniz S., Vollmer M.A. Adult norms for a commercially available Nine Hole Peg Test for finger dexterity. Am J Occup Ther 2003, 57:570-573.
43. American College of Sports Medicine ACSM's guidelines for exercise testing and prescription 2009, Lippincott Williams & Wilkins, Philadelphia, PA. 7th ed. M.H. Whaley (Ed.).